ARM’s annual Congressional Fly-In will be held July 15-16, 2024. For this program, ARM members will come together to represent the cell and gene therapy sector to policymakers on Capitol Hill. This Fly-In will provide the opportunity to share the sector’s promise and priorities with the Representatives and Senators who act on behalf our members’ districts and states. These voices are critical to ensuring that policymakers understand the unique nature of these therapies and the policies needed to deliver them to patients.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,100 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.